Fetal growth, length of gestation, and polycystic ovaries in adult life

Lancet

Volumn 350, Issue 9085, 1997, Pages 1131-1135

  Cresswell, J L ^a   Barker, D J P ^b   Osmond, C ^b   Egger, P ^b   Phillips, D I W ^b   Fraser, R B ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; ARTICLE; BODY SIZE; FEMALE; FETUS; FETUS GROWTH; HIRSUTISM; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PREGNANCY; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; UNITED KINGDOM;

EID: 0030680199     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)06062-5     Document Type: Article

References (25)

1. Stein IF, Levanthal ML. Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181-91.
2. Franks S, Adams J, Mason H, Polson D. Ovulatory disorders in women with polycystic ovary syndrome. Clin Obstet Gynaecol 1985; 12: 605-32.
3. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries: a common finding in normal women. Lancet 1988; i: 870-72.
4. Franks S. Polycystic ovary syndrome. N Engl J Med 1985; 333: 853-61.
5. Burghen GA, Givens JR, Kitabachi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980; 50: 113-16.
6. Dunaif A. Insulin resistance and ovarian dysfunction. In: Moller DE, ed. Insulin resistance, Chichester: Wiley, 1993: 301-26.
7. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 1992; 37: 119-25.
8. Pasquali R, Casinirri F. The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol (Oxf) 1993; 39: 1-16.
9. Yen SSC, Vela P, Rankin J. Inappropriate secretion of follicle stimulating hormone and luteinising hormone in polycystic ovarian disease. J Clin Endocrinol Metab 1970; 30: 435-42.
10. Erikson GF, Hsueh AJW, Quigley ME, Rebar RW, Yen SSC. Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. J Clin Endocrinol Metab 1979; 49: 514-19.
11. Rosenfield RL, Barnes RB, Cara JF, Lucky AW. Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome. Fertil Steril 1990; 53: 785-91.
12. Yen SCC. The polycystic ovary syndrome. Clin Endocrinol (Oxf) 1980; 12: 177-208.
13. Barker DJP, Winter PD, Osmond C, Phillips DIW, Sultan HY. Weight gain in infancy and cancer of the ovary. Lancet 1995; 345: 1087-88.
14. Phillips DIW. Insulin resistance as a programmed response to intrauterine undernutrition. Diabetologia 1996; 39: 1119-22.
15. Pfeiffer CA. Sexual differences of the hypophyses and their determination by the gonads. Am J Anat 1936; 58: 195-225.
16. Barraclough CA, Gorski RA. Evidence that the hypothalamus is responsible for androgen-induced sterility in the female rat. Endocrinology 1961; 68: 68-79.
17. Barraclough CA. Production of anovulatory, sterile rats by single injections of testosterone propionate. Endocrinology 1961; 68: 62-67.
18. Vom Saal FS, Bronson FH. Sexual characteristics of adult female mice are correlated with their blood testosterone levels during prenatal development. Science 1980; 208: 597-99.
19. Adams J, Franks S, Polson DW, et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 1985; ii: 1375-78.
20. Ferriman D, Gallway JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-47.
21. Fiore MD, Mitchell J, Doan T, et al. The Abbott IMx automated benchtop immunochemistry analyser system. Clin Chem 1988; 34: 1726-32.
22. Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol 1989; 30: 459-70.
23. Gruenwald P. Pathology of the deprived fetus and its supply line. In: Elliott K, Knight J, eds. Size at birth: Ciba Foundation Symposium No 27. Amsterdam: Elsevier, 1974: 3-19.
24. Hague WM, Adams J, Reeders ST, Peto TEA, Jacobs HS. Familial polycystic ovaries: a genetic disease? Clin Endocrinol 1988; 29: 593-605.
25. Ehrmarn DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocrinol Rev 1995; 16: 322-53.